Announcing its Q4FY22 results, Madhabbagh, a brand of Vaidya Sane Ayurveda Laboratories Limited, has increased its net profit after tax (PAT) by 785 per cent in FY2021-22. According to the details provided by the company, Madhabbagh’s net profit in FY 22 was Rs 3.46 crore as compared to Rs 39 lakh in FY21.
Madhabbagh, which operates 272 clinics and 2 hospitals across eight states of India, had a total revenue of Rs 75.04 crore in FY22, an increase of 43 per cent from Rs 52.37 crore in FY22 and its EBIDTA increased by 66 per cent from Rs 4.36 crore. According to the statement, Rs 7.25 crore to Rs 7.25 crore at the same time.
Commenting on the Q4FY22 results, Dr. Rohit Sane, MD & CEO, Vaidya Sane Ayurveda Laboratories Ltd. (Madhabbagh), said, Has achieved turnover. From all departments after overcoming obstacles like lockdown in the early months of the year. Both of our clinics, which include company-owned and hospital-owned franchised clinics, have recorded the highest revenue and EBIDTA to date. During this reporting period, we continue to focus on collaborating with industry market players throughout our business to achieve efficient patient service and future growth. “
“In FY 2022-23, Madhabbagh is committed to providing NABH approvals for education companies, insurance companies, corporates, hospitals and clinics, including a model for educating physicians, with a view to serving patients more efficiently,” he added.